학술논문
Time-Averaged LDL-C Lowering with Evolocumab: Pooled Analysis of Phase 2 Trials
Document Type
Abstract
Author
Source
In Journal of Clinical Lipidology January-February 2022 16(1) Supplement:e31-e31
Subject
Language
ISSN
1933-2874